Approval · Notice of Compliance 12197 · 2011
ELOCOM: Notice of Compliance 12197
Issued March 21, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12197
- Date
- March 21, 2011
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Corticosteroid
Products in this notice
Medicinal ingredients
- MOMETASONE FUROATE 0.1 PER
- MOMETASONE FUROATE 1 MG per G